Rising incidence of cancer is one of the most significant factors influencing the market growth. Market Size – USD 396.4 Million in 2019, Market Growth – CAGR of 4.1%, Market Trends –Growing demand for a minimally invasive procedure.
The global brachytherapy market size was valued at USD 396.4 Million in 2019 and is forecasted to reach USD 548.8 Million by 2027 at a CAGR of 4.1%. The brachytherapy market is experiencing an increased demand attributed to its growing application in cancer treatment such as prostate cancer, gynecological cancer, breast cancer, and skin cancer. Factors such as rising cancer incidence, growing demand for minimally invasive procedures, and growing awareness about the disease in emerging economies drive the market growth.
The latest market intelligence study on the Brachytherapy Market brings in the best of both qualitative and quantitative assessment techniques to explore the market size, share, and status of the Brachytherapy Market for the forecast period, 2020 – 2027. The extensive examination of the global business environment provides a detailed analysis of the key driving forces and challenges with the aim to give the stakeholders, business owners, and filed marketing executives a competitive advantage over others. The study further probes into prominent challenges, technology advancements, current trends and lucrative avenues often considered as the boosting elements for the Brachytherapy Market for the forecast period, 2020 – 2027.
Segments Covered in the report
Type Outlook (Revenue, USD Billion; 2017-2027)
High Dose Rate (HDR) Brachytherapy
Low Dose Rate (LDR) Brachytherapy
Application Outlook (Revenue, USD Billion; 2017-2027)
End Users Outlook (Revenue, USD Billion; 2017-2027)
Regional Outlook (Revenue, USD Billion; 2017-2027)
Key Highlights From The Report
In April, 2020, Elekta announced the introduction of a universal gynecological brachytherapy applicator, Geneva, which was designed deploying the outside-in methodology of Elekta, which caters to the growing needs of front-line cancer therapists.
Low-dose rate (LDR) brachytherapy is likely to grow at the fastest rate of x% in the forecast period. The radioactive sources, in LDR, are placed inside or directly beside the tumor and may be left in the target location permanently. Prostate cancer is the most commonly treated condition using Low dose rate brachytherapy.
Breast cancer is the most commonly occurring cancer type in women, with more than 2 million new breast cancer cases in 2018. The global breast cancer survival rates vary greatly, ranging from around 80% in North America, Japan, and Sweden to nearby 60% in middle-income nations and lower than 40% in low-income nations.
Specialty clinics are equipped with the requisite radiotherapy instrument & devices and specialist staff to assist in diagnosing cancer and adopting a suitable procedure for disease treatment.
The brachytherapy market in the Asia Pacific region is likely to grow at the fastest rate of 5.6% in the forecast period due to the growing incidence and occurrence of cancer, the increasing prevalence of health insurance, and improving reimbursement policies.
Key participants include Elekta AB, CR Bard Inc., Varian Medical Systems Inc., Eckert & Ziegler BEBIG SA, CIVCO Medical Solutions, iCAD Inc., Isoray Medical Inc., Sun Nuclear Corporation, Theragenics Corporation, and Huiheng Medical Inc., among others.
You Can Download Free Sample PDF Copy of Brachytherapy Market at https://www.emergenresearch.com/request-sample/183
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Brachytherapy Market Segmentation & Impact Analysis
4.1. Brachytherapy Market Material Segmentation Analysis
4.2. Industrial Outlook
Chapter 5. Brachytherapy Market By Type Insights & Trends, Revenue (USD Million)
Chapter 6. Brachytherapy Market By Application Insights & Trends Revenue (USD Million)
Chapter 7. Brachytherapy Market By End-Users Insights & Trends Revenue (USD Million)
Chapter 8. Brachytherapy Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs